Prospective Collection of Female and Male Specimens for PANTHER® System Testing

CompletedOBSERVATIONAL
Enrollment

1,492

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Chlamydia InfectionsGonorrhea
Interventions
DEVICE

APTIMA Assays; PANTHER System

APTIMA Assays; PANTHER System

Trial Locations (16)

21205

John Hopkins University, Baltimore

23502

Tidewater Clinical Research, Inc. -Tidewater Physicians for Women, Norfolk

27215

Laboratory Corporation of America, Burlington

33012

AGA Clinical Trials, Hialeah

35294

University of Alabama at Birmingham, Birmingham

37804

Molecular Pathology Laboratory Network, Inc., Maryville

46202

Wishard Health Services, Indianapolis

55415

Hennepin County Medical Center, Minneapolis

70112

Louisiana State University Health Sciences, New Orleans

77023

Planned Parenthood Houston and Southeast Texas, Houston

90069

Anthony Mills MD Inc., Los Angeles

94102

Benchmark Research, San Francisco

06511

Planned Parenthood Southern New England, New Haven

02744

New England Center for Clinical Research - New Bedford Clinic, New Bedford

27599-7030

University of North Carolina Chapel Hill, Chapel Hill

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Gen-Probe, Incorporated

INDUSTRY

NCT01638637 - Prospective Collection of Female and Male Specimens for PANTHER® System Testing | Biotech Hunter | Biotech Hunter